跳至主要内容
临床试验/JPRN-UMIN000042695
JPRN-UMIN000042695
已完成
3 期

A Comparative Clinical Trial for Critical Limb Ischemia with Paclitaxel Coating Balloon Catheter (JLL-LEG). - The JLL-LEG Pivotal Trial

Japan Lifeline Co., Ltd.0 个研究点目标入组 160 人2020年12月9日

概览

阶段
3 期
干预措施
未指定
疾病 / 适应症
Critical Limb Ischemia
发起方
Japan Lifeline Co., Ltd.
入组人数
160
状态
已完成
最后更新
2年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2020年12月9日
结束日期
2020年4月14日
最后更新
2年前
研究类型
Interventional
性别
All

研究者

入排标准

入选标准

  • 未提供

排除标准

  • (1\) Subject who undergoes EVT as a pretreatment for major amputation or who is expected to cannot avoid major amputation even if EVT is performed. (2\) Subject with severe heart failure. (3\) Subject with untreated severe coronary artery disease. (4\) Subject with severe infection. (5\) Subject with ulcers on the heel. (6\) Subject with inflammation extending to the sole of the foot. (7\) Subject with accumulated pus in the wounds. (8\) Subject with taking steroids. (9\) Subject with albumin value less than 2\.5 g/dl. (10\) Subject with low ADL (WHO PS score of 4 or more). Except when it is caused by the underlying disease. (11\) Subject with ulcers that are unlikely to becaused by lower limb ischemia, because lower limb blood flow is evaluated to be sufficiently by objective blood flow assessment (angiography, echo, etc.). (12\) Subject with ulcers caused by primary diseases other than arteriosclerosis such as vasculitis. (13\) Subject with major amputation on the contralateral limb. (14\) Subject with Rutherford categories 6 on the contralateral limb. (15\) Subject with pregnant or possibly pregnant and lactating. (16\) Subject with hypersensitivity reaction to aspirin, heparin, clopidogrel or ticlopidine. (17\) Subject with a history of contraindications or allergies to contrast agents. However, subject with a history of allergies are excluded when preoperative administration of steroids can prevent symptoms. (18\) Subject with bleeding tendency or abnormal blood coagulation, who cannot perform emergency blood transfusion, or who is contraindicated for antiplatelet drugs. (19\) Subject with stroke or transient ischemic attack (TIA) within 6 months before preoperative. (20\) Subject with treatment history of abdominal aorta within 1 month before preoperative. (21\) Subject who have paclitaxel\-eluting stents placed on the target limbs within 1 year before preoperative.

结局指标

主要结局

未指定

相似试验